Camurus, Braeburn deal

Camurus granted Braeburn exclusive, North American rights to buprenorphine injection depot ( CAM2038) to

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE